Launay et al compare the persistence of cross-neutralizing antibodies up to 3 months post-booster. The monovalent (MV) recombinant protein Beta-variant (MVB.1.351) vaccine induces higher and durable cross-neutralizing antibodies against Omicron subvariants compared to MV ancestral protein (MVD614) and mRNA MV ancestral strain BNT162b2 vaccines.
- Odile Launay
- Rachna Gupta
- Tabassome Simon